CNS Pharmaceuticals
$2.379876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.12 (+5.33%) Today
$0.00 (0.00%) As of 4:28 PM EST after-hours
Why Robinhood?
You can buy or sell CNSP and other stocks, options, and ETFs commission-free!
About CNSP
CNS Pharmaceuticals, Inc. Common Stock, also called CNS Pharmaceuticals, is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX. The listed name for CNSP is CNS Pharmaceuticals, Inc. Common Stock.
CEO
John M. Climaco
Employees
5
Headquarters
Houston, Texas
Founded
2017
Market Cap
39.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.23K
High Today
$2.45
Low Today
$2.20
Open Price
$2.25
Volume
150.46K
52 Week High
$5.62
52 Week Low
$1.26
Collections
CNSP Earnings
-$0.17
-$0.11
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.12 per share
Actual
-$0.12 per share